Health Care Distributors

Among the distributors, J.P. Morgan said that it favors McKesson Corporation (NYSE: MCK) and Cardinal Health, Inc. (NYSE: CAH). “We continue to believe that MCK is underappreciated, as the distribution business continues to successfully expand generic penetration and EBIT growth continues to be the...

Morgan Stanley has updated its model to incorporate Cardinal Health, Inc.'s (NYSE: CAH) Kinray and Yong Yu acquisitions. “For FY11, we now forecast non-GAAP EPS of $2.52 (from $2.50) and cash EPS of $2.58,vs. consensus' $2.51 and management's guidance range of $2.38-2.48, which excludes strategic...

Shares of Pharmerica Corporation (NYSE: PMC) are currently up 9.6% at $12.87 per share during Tuesday afternoon trading. PharMerica Corporation announced on Monday that it had acquired Garland, Texas-based Lone Star Pharmacy. Today's trading range for shares of PharMerica Corporation (PMC) has been...

Standpoint Research Downgrades McKesson (NYSE: MCK) from Buy to Hold

Henry Schein (HSIC) has completed the acquisition of Australia based Provet Holdings, the largest veterinary products distributor in Australia having $278 million in revenues for the fiscal year ended in June 2010. Earlier, in October 2010, Henry Schein had announced its decision to acquire...

Henry Schein (HSIC) has completed the acquisition of Australia based Provet Holdings, the largest veterinary products distributor in Australia having $278 million in revenues for the fiscal year ended in June 2010. Earlier, in October 2010, Henry Schein had announced its decision to acquire...

PharMerica Corporation (NYSE: PMC) announced today that it has acquired substantially all the assets of Lone Star Pharmacy based in Garland, Texas.

Chindex International, Inc. (Nasdaq: CHDX) and Shanghai Fosun Pharmaceutical Co., Ltd. today announced the formation of the previously-proposed joint venture to independently operate certain combined medical device businesses, including Chindex's Medical Products division. The formation of the...

We maintain our Neutral recommendation on BioScrip Inc. (BIOS) following its tepid third-quarter fiscal 2010 results. Earnings for the quarter trailed both the Zacks Consensus Estimate and the year-ago earnings. Profit plummeted 66% year over year, hit by higher costs and tax. On a positive...

We maintain our Neutral recommendation on BioScrip Inc. (BIOS) following its tepid third-quarter fiscal 2010 results. Earnings for the quarter trailed both the Zacks Consensus Estimate and the year-ago earnings. Profit plummeted 66% year over year, hit by higher costs and tax. On a positive...

MWI Veterinary Supply, Inc. (MWIV) recently hit a new all-time high at $64.73 after rallying into the end of the year on a Q4 earnings surprise of 16% from early November. With an average earnings surprise of 23% Over the last four quarters and bullish growth projection of 14%, this Zacks #1 rank...

MWI Veterinary Supply, Inc. (MWIV) recently hit a new all-time high at $64.73 after rallying into the end of the year on a Q4 earnings surprise of 16% from early November. With an average earnings surprise of 23% Over the last four quarters and bullish growth projection of 14%, this Zacks #1 rank...

Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination of waiting period...

Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination of waiting period...

Goldman Sachs is reiterating its Conviction Buy rating and $38 price target on shares of AmerisourceBergen Corp. (NYSE: ABC). In a note sent to clients, Goldman writes, "Today, AmerisourceBergen held its annual Investor Day in New York where management remains “bullish” on the business and its...